Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kurz Italia is the Italian subsidiary of Heinz Kurz GmbH, a prominent German medical technology firm specializing in otology and otorhinolaryngology. The company focuses on the distribution and technical support of high-precision middle ear implants used in reconstructive surgery. Their product portfolio includes advanced stapes prostheses, total and partial ossicular replacement prostheses (TORP and PORP), and ventilation tubes. These devices are primarily constructed from biocompatible materials such as titanium and nitinol to ensure long-term stability and optimal acoustic performance. Kurz Italia serves as a vital partner for ENT surgeons across Italy, providing specialized instrumentation and educational resources for complex ear surgeries. The company's solutions are designed to treat conductive hearing loss resulting from conditions like otosclerosis and chronic middle ear disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Istituto Kurz Italia.